Radiopharmaceuticals are medicinal products containing radionuclides that emit radiation for diagnostic imaging or therapeutic purposes. They are used in procedures such as positron emission tomography, single-photon emission computed tomography, and targeted radionuclide therapy. Unlike conventional medicines, these products require additional controls because their radioactive properties change over time and may create radiation exposure risks. Storage and distribution systems therefore combine pharmaceutical quality management with radiation protection and specialized transportation procedures. Their design depends on the radionuclide, product formulation, activity level, intended use, and applicable national regulations.
Radiopharmaceutical storage systems are designed to preserve product quality while limiting unnecessary radiation exposure. Storage conditions vary according to the product's approved specifications, chemical stability, physical form, and radioactive characteristics. Some products require refrigeration, while others must be maintained at controlled room temperature or under specific preparation conditions. Certain short-lived radiopharmaceuticals may need to be used soon after production.
Facilities generally establish designated storage areas with suitable shielding, access controls, radiation monitoring, and procedures for handling radioactive materials. Storage arrangements must also separate products when necessary to prevent mix-ups, contamination, or incompatible storage conditions.
Important elements of radiopharmaceutical storage include:
Radiation shielding: Appropriate shielding materials, such as lead or tungsten, help reduce exposure from stored radioactive products. The required shielding depends on the radionuclide and radiation energy.
Temperature monitoring: Validated storage equipment and monitoring procedures help maintain the conditions specified for each product.
Inventory management: Records of product identity, batch details, activity, receipt time, expiry information, and storage location support traceability.
Radiation monitoring: Suitable instruments and workplace surveys help identify unexpected radiation levels or contamination.
Access control: Authorized personnel procedures reduce the risk of inappropriate handling and improve accountability.
Waste management: Radioactive waste must be segregated, labeled, stored, and managed according to applicable requirements.
Staff training is another essential component. Personnel need to understand radiation protection, contamination prevention, emergency procedures, and the correct handling of specific products. Written procedures and routine equipment checks help maintain consistent storage practices.
Radiopharmaceutical distribution involves coordinating production facilities, specialized transport providers, nuclear medicine departments, hospitals, and diagnostic centers. The process must protect the product, maintain accurate documentation, and meet relevant transportation and pharmaceutical quality requirements.
A major consideration is radioactive decay. A radionuclide's activity decreases over time according to its half-life, which can affect the amount of activity available when a product reaches its destination. Consequently, production schedules, dispatch arrangements, transport duration, and appointment times must be coordinated carefully.
Key distribution considerations include:
Transport packaging: Packages must meet applicable requirements for radioactive materials, including suitable containment, shielding where necessary, labeling, and documentation.
Delivery scheduling: Coordinated dispatch and receipt times help ensure products arrive within their permitted use periods.
Product traceability: Shipment records connect product identification, batch information, dispatch details, and receipt confirmation.
Quality assurance: Defined checks help verify product identity, integrity, and compliance with applicable specifications.
Regulatory compliance: Transporters and healthcare facilities must follow relevant national rules and applicable international standards.
Contingency planning: Procedures for delays, damaged packages, unexpected contamination, or transport disruptions help support safe responses.
Distribution systems may use validated packaging, temperature-control equipment, shipment tracking, and electronic inventory records. Digital tools can improve visibility across the supply chain, although they do not replace required physical inspections, radiation surveys, or regulatory documentation.
Effective coordination between manufacturers, transport personnel, and receiving facilities supports the reliable availability of radiopharmaceuticals. By combining appropriate storage conditions, radiation protection, traceability, and carefully planned logistics, these systems help maintain the quality and safety of products used in diagnostic imaging and radionuclide therapy. Requirements differ by product and jurisdiction, so facilities must follow the applicable product information and regulatory guidance.